UNOS statement regarding Medicare billing guidance for organ transplant monitoring tests
UNOS statement regarding the Medicare billing guidance on molecular testing for solid organ allograft rejection
UNOS statement on draft OPTN request for proposals
UNOS CEO statement on the draft OPTN request for proposals issued on February 6, 2024
UNOS strengthens leadership team
Several new leaders will play integral roles in advancing UNOS’ mission to strengthen the organ donation and transplant system.
UNOS hires new Vice President of External Affairs
The external affairs team advocates for impactful policies and legislation on behalf of transplant patients with the mission of saving as many lives as possible.
UNOS statement on testing environment situation
UNOS is currently investigating a configuration error that may have permitted access by authorized users to some patients’ personal and health information.
UNOS statement following December UNOS Board vote
The new UNOS Board of Directors will go into effect on March 30, 2024, the day after UNOS’ OPTN contract with the federal government ends.